ProQR Therapeutics N.V. (NASDAQ:PRQR) has 67 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 6,253,467 | 0 | 0.00% | $10,130,617.00 |
| Privium Fund Management B.V. | 31 Mar, 2026 | 5,467,149 | 109,387 | 2.04% | $8,856,781.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 3,316,965 | 366,289 | 12.41% | $5,373,483.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 2,454,278 | 0 | 0.00% | $3,975,930.00 |
| Sio Capital Management, LLC | 31 Mar, 2026 | 1,954,715 | -209,466 | -9.68% | $3,166,638.00 |
| DAFNA Capital Management LLC | 31 Mar, 2026 | 1,567,561 | 0 | 0.00% | $2,539,449.00 |
| Kynam Capital Management, LP | 31 Mar, 2026 | 1,566,317 | 0 | 0.00% | $2,537,434.00 |
| Ikarian Capital, LLC | 31 Mar, 2026 | 1,492,229 | 0 | 0.00% | $2,417,411.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,299,775 | -67,344 | -4.93% | $2,105,635.00 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 31 Mar, 2026 | 1,235,514 | 0 | 0.00% | $2,001,533.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 918,857 | 79,473 | 9.47% | $1,488,548.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 755,842 | -57,808 | -7.10% | $1,224,464.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 703,323 | 120,101 | 20.59% | $1,139,383.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Mar, 2026 | 620,000 | 0 | 0.00% | $1,004,000.00 |
| Walleye Capital LLC | 31 Mar, 2026 | 607,529 | 15,744 | 2.66% | $984,197.00 |
| M28 Capital Management LP | 31 Mar, 2026 | 599,793 | -419,705 | -41.17% | $971,665.00 |
| Raymond James Financial Inc | 31 Mar, 2026 | 546,079 | 203,193 | 59.26% | $884,648.00 |
| Monaco Asset Management SAM | 31 Mar, 2026 | 418,803 | -10,000 | -2.33% | $678,461.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Mar, 2026 | 355,283 | 0 | 0.00% | $575,558.00 |
| UBS Group AG | 31 Mar, 2026 | 305,264 | -492,400 | -61.73% | $494,528.00 |